Qube Research & Technologies (QRT)’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.41M Buy
349,661
+55,962
+19% +$865K 0.01% 1211
2025
Q1
$4.37M Buy
293,699
+113,761
+63% +$1.69M 0.01% 1262
2024
Q4
$2.38M Buy
179,938
+49,821
+38% +$660K ﹤0.01% 1431
2024
Q3
$1.85M Buy
+130,117
New +$1.85M ﹤0.01% 1440
2024
Q2
Sell
-114,209
Closed -$1.59M 4153
2024
Q1
$1.59M Sell
114,209
-319,309
-74% -$4.44M ﹤0.01% 1600
2023
Q4
$6.19M Buy
433,518
+146,813
+51% +$2.1M 0.01% 777
2023
Q3
$4.44M Sell
286,705
-444,953
-61% -$6.88M 0.01% 784
2023
Q2
$11.5M Buy
731,658
+394,761
+117% +$6.2M 0.04% 463
2023
Q1
$5.55M Buy
+336,897
New +$5.55M 0.02% 580
2022
Q2
Sell
-218,322
Closed -$3.13M 3091
2022
Q1
$3.13M Buy
218,322
+15,874
+8% +$227K 0.03% 638
2021
Q4
$2.76M Buy
202,448
+7,368
+4% +$100K 0.02% 717
2021
Q3
$3.2M Buy
+195,080
New +$3.2M 0.04% 546
2021
Q2
Sell
-188,713
Closed -$3.45M 2779
2021
Q1
$3.45M Sell
188,713
-9,598
-5% -$175K 0.05% 451
2020
Q4
$3.61M Sell
198,311
-280,588
-59% -$5.11M 0.05% 400
2020
Q3
$8.54M Buy
478,899
+352,389
+279% +$6.29M 0.12% 209
2020
Q2
$2.27M Buy
+126,510
New +$2.27M 0.03% 620
2020
Q1
Sell
-94,412
Closed -$1.86M 1642
2019
Q4
$1.86M Buy
94,412
+64,525
+216% +$1.27M 0.06% 384
2019
Q3
$514K Sell
29,887
-2,913
-9% -$50.1K 0.34% 85
2019
Q2
$581K Buy
+32,800
New +$581K 0.14% 160
2019
Q1
Sell
-69,304
Closed -$1.17M 470
2018
Q4
$1.17M Buy
+69,304
New +$1.17M 0.5% 27